Skip to main content
SpringerLink
Log in

Behavioral and Neuropathological Consequences of Chronic Exposure to Low Doses of the Dopaminergic Neurotoxin MPTP

  • Chapter
The Vulnerable Brain and Environmental Risks

Abstract

This chapter will discuss the consequences of exposure to the neurotoxin MPTP in nonhuman primates, and particularly the consequences of chronic exposure to low doses of this toxin. Before such a discussion can proceed, some background material about MPTP, its effects on the central nervous system, and the clinical manifestations of these effects needs to be presented.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Alexander, G.E., DeLong, M.R., and Strick, P.L., 1986, Parallel organization of functionally segregated circuits linking basal ganglia and cortex, Ann. Rev. Neurosci. 9:357–381.

    Article  PubMed  CAS  Google Scholar 

  • Arnsten, A.F.T., and Goldman-Rakic, P.S., 1985, Alpha-2 adrenergic mechanisms in prefrontal cortex associated with cognitive decline in aged non-human primates, Science 230:1273–1276.

    Article  PubMed  CAS  Google Scholar 

  • Ballard, P.A., Tetrud, J.W., and Langston, J.W., 1985, Permanent human parkinsonism due to 1-methyl-4-phenyl-l,2,3,6tetrahydropyridine (MPTP): Seven cases, Neurology 35:949–956.

    Article  PubMed  CAS  Google Scholar 

  • Battig, K., Rosvold, H.E., and Mishkin, M., 1960, Comparison of the effects of frontal and caudate lesions on delayed response and alternation in monkeys, J. Comp. Psycho!. 53:400–404.

    Article  CAS  Google Scholar 

  • Boyce, S., Rupniak, N.M.J., Steventon, M.J., and Iversen, S.D., 1990, Differential effects of Dl and D2 agonists in MPTPtreated primates: Functional implications for Parkinson’s disease, Neurology 40:927–933.

    Article  PubMed  CAS  Google Scholar 

  • Brozoski, T., Brown, R.M., Rosvold, H.E., and Goldman, P.S., 1979, Cognitive deficit caused by regional depletion of dopamine in prefrontal cortex of rhesus monkey, Science 205:929–931.

    Article  PubMed  CAS  Google Scholar 

  • Bums, R.S., Chiueh, C., Markey, S.P., Ebert, M.H., Jacobowitz, D.M., and Kopin, I.J., 1983, A primate model of parkinsonism: Selective destruction of dopaminergic neurons in the pars compacta substantia nigra by MPTP, Proc. Natl. Acad. Sci USA 80:4546–4550.

    Article  Google Scholar 

  • Clarke, C.E., Sandbrook, M.A., Mitchell, I.J., and Crossman, A.R., 1987, Levodopa-induced dyskinesia and response fluctuations in primates rendered parkinsonian with 1-methyl-4-phenyl,1,2,3,6-tetrahydropyridine (MPTP), J. Neurol. Sci., 78:273–280.

    Article  PubMed  CAS  Google Scholar 

  • Davis, G.C., Williams, A.C., Markey, S.P., Ebert, M.H., Caine, E.D., Reichert, C.M., and Kopin, I.J., 1979, Chronic parkinsonism secondary to intravenous injection of meperidine analogues, Psychiat. Res. 1:249–254.

    Article  CAS  Google Scholar 

  • Diamond, A., 1990, Developmental time course in human and infant monkeys, and the neural bases of, inhibitory control in reaching, in: The Development and Neurol Bases of Higher Cognitive Functions Volume 608, Annals of the New York Academy of Sciences (A. Diamond, ed.), The New York Academy of Sciences, New York, pp. 637–677.

    Google Scholar 

  • Divac, I., Rosvold, H.E., and Szarcbart, M.K., 1967, Behavioral effects of selective ablation of the caudate nucleus, J. Comp. Physiol. Psycho!. 63:184–190.

    Article  CAS  Google Scholar 

  • Forno, L.S., 1982, Pathology of Parkinson’s disease, in: Movements Disorders (C.D. Marsden and S. Fahn, eds.), Butterworth, London, pp. 25–40.

    Google Scholar 

  • Fomo, L.S., 1986, The Lewy body in Parkinson’s disease, in: Advances in Neurology, Volume 45 (M.D. Yahr and K.J. Bergmann, eds.), Raven Press, New York, pp. 35–50.

    Google Scholar 

  • Forno, L.S., Langston, J.W., DeLanney, L.E., Irwin, I., and Ricaurte, G.A., 1986, Locus ceruleus lesions and eospinophilic inclusions in MPTP-treated monkeys, Ann. Neurol. 20:449–455.

    Article  PubMed  CAS  Google Scholar 

  • Freedman, M., and Oscar-Berman, M., 1986, Selective delayed response deficits in Parkinson’s and Alzheimer’s disease, Arch. Neurol. 43:886–890.

    Article  PubMed  CAS  Google Scholar 

  • German, D.C., Manaye, K., Smith, W.K., Woodward, D.J., and Saper, C.B., 1989, Midbrain dopaminergic cell loss in Parkinson’s disease: Computer visualization, Ann. Neurol. 26:507–514.

    Article  PubMed  CAS  Google Scholar 

  • Goldman, P.S., and Rosvold, H.E., 1972, The effects of selective caudate lesions in juvenile rhesus monkeys, Brain Res. 43:53–66.

    Article  PubMed  CAS  Google Scholar 

  • Homykiewicz, O., and Kish, S.J., 1986, Biochemical pathophysiology of Parkinson’s disease, in: Advances in Neurology,Volume 45 (M.D. Yahr, and K.J. Bergmann, eds.), Raven Press, New York, pp. 19–34.

    Google Scholar 

  • Jellinger, K., 1986, Overview of morphological changes in Parkinson’s disease, in:Advances in Neurology, Volume 45 (M.D. Yahr, and K.J. Bergmann, eds.), Raven Press, New York, pp. 1–18.

    Google Scholar 

  • Johnston, C.W., 1986, The neuropsychological evaluation of attention deficit disorder, Psychiatr. Ann. 16:47–51.

    Google Scholar 

  • Langston, J.W., Ballard, P., Tetrud, J.W., and Irwin, I., 1983, Chronic parkinsonism in humans due a product of medperidineanalogue synthesis, Science 219:979–980.

    Article  PubMed  CAS  Google Scholar 

  • Langston, J.W., Irwin, I., and Ricaurte, G.A., 1987, Neurotoxins, parkinsonism and Parkinson’s disease, Pharmac. Ther. 32:19–49.

    Article  CAS  Google Scholar 

  • Lau, H.C., Henricksen, L., and Bruhn, P., 1984, Focal cerebral hypoperfusion in children with dysphasia and/or attention deficit disorder, Arch. Neurol. 41:825–829.

    Article  Google Scholar 

  • Levin, B.E., Llabre, N.M., and Weiner, W.J., 1989, Cognitive impairments associated with early Parkinson’s disease, Neurology 39:557–561.

    Article  PubMed  CAS  Google Scholar 

  • Mesulam, M.M., 1985, Principles of Behavioral Neurology,F.A. Davis, Philadelphia, p. 29.

    Google Scholar 

  • Pifl, Ch., Schingnitz, G., and Homykiewicz, O., 1988, The neurotoxin MPTP does not produce in the rhesus monkey, the interregional pattern of striatal dopamine loss typical of human idiopathic Parkinson’s disease, Neurosci. Lea. 92:228–233.

    Article  CAS  Google Scholar 

  • Roeltgen, M.G., Roeltgen, D.P., and Heilman, K.M., 1989, Unilateral motor impersistence and hemispatial neglect from a right striatal lesion, Neuropsychol. Neuropsychiatry Behay. Neurol. 2:125–135.

    Google Scholar 

  • Roeltgen, D.P., and Schneider, J.S., 1991, Chronic low-dose MPTP in non-human primates: A possible model for attention deficit disorder, J. Child Neurol. 6:582–589.

    Google Scholar 

  • Schneider, J.S., 1990, Chronic exposure to low doses of MPTP. II. Neurochemical and pathological consequences in cognitively-impaired, motor asymptomatic monkeys, Brain Res. 534:25–36.

    Article  PubMed  CAS  Google Scholar 

  • Schneider, J.S., and Kovelowski, C.J., 1990, Chronic exposure to low doses of MPTP. I. Cognitive deficits in motor asymptomatic monkeys, Brain Res. 519:122–128.

    Article  PubMed  CAS  Google Scholar 

  • Schneider, J.S., Yuwiler, A., and Markham, C.H., 1986, Production of a Parkinson-like syndrome in the cat with N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): Behavior, histology, and biochemistry, Exp. Neurol. 91:293–307.

    Article  PubMed  CAS  Google Scholar 

  • Schneider, J.S., Yuwiler, A., and Markham, C.H., 1987, Selective loss of subpopulations of ventral metencephalic dopaminergic neurons in the monkey following exposure to MPTP, Brain Res. 411:144–150.

    Article  PubMed  CAS  Google Scholar 

  • Schneider, J.S., Unguez, G., Yuwiler, A., Berg, S.C., and Markham, C.H., 1988, Deficits in operant behavior in monkeys treated with N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), Brain 111:1265–1285.

    Article  PubMed  Google Scholar 

  • Sharpe, M.H., 1990, Distractibility in early Parkinson’s disease, Cortex 26:239–246.

    PubMed  CAS  Google Scholar 

  • Stem, Y., and Langston, J.W., 1985, Intellectual changes in patients with MPTP-induced parkinsonism, Neurology 35:1506–1509.

    Article  PubMed  CAS  Google Scholar 

  • Stern, Y., Tetrud, J.W., Martin, W.R.W., Kutner, S.J., and Langston, J.W., 1990, Cognitive change following MPTP exposure, Neurology 40:261–264.

    Article  PubMed  CAS  Google Scholar 

  • Taylor, A.E., Saint-Cyr, J.A., and Lang, A.E., 1986, Frontal lobe dysfunction in Parkinson’s disease, Brain 109:345–383.

    Article  Google Scholar 

  • Voeller, K.K.S., Alexander, A.W., Carter, R.L., and Heilman, K.M., 1989, Motor impersistence in children with attention deficit hyperactivity disorder decreases in response to treatment with methylphenidate, Neurology 39 (Suppl 1): 276.

    Google Scholar 

  • Wilson, J.S., and Wilson, J.A. 1986, Intracellular recordings in the caudate nucleus of normal and MPTP treated dogs, in: MPTP: A Neurotoxin Producing a Parkinsonian Syndrome (S.P. Markey, N. Castagnoli, A.J. Trevor, and I.J. Kopin, eds.), Academic Press, Orlando, pp. 695–699.

    Google Scholar 

  • Zamir, N., Skofitsch, G., Bannen, N.J., Helke, C.J., Kopin, I.J. and Jacobowitz, D.M., 1984, Primate model of Parkinson’s disease: Alterations in multiple opiod systems in the basal ganglia, Brain Res. 322:356–360.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Center for Neurological Research of the Department of Neurology, Hahnemann University School of Medicine, Philadelphia, Pennsylvania, 19102, USA

    J. S. Schneider

Authors
  1. J. S. Schneider
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Binghamton University, Binghamton, New York, USA

    Robert L. Isaacson

  2. U. S. Environmental Protection Agency, Research Triangle Park, North Carolina, USA

    Karl F. Jensen

Rights and permissions

Reprints and permissions

Copyright information

© 1992 Springer Science+Business Media New York

About this chapter

Cite this chapter

Schneider, J.S. (1992). Behavioral and Neuropathological Consequences of Chronic Exposure to Low Doses of the Dopaminergic Neurotoxin MPTP. In: Isaacson, R.L., Jensen, K.F. (eds) The Vulnerable Brain and Environmental Risks. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-3330-6_16

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-3330-6_16

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-6467-2

  • Online ISBN: 978-1-4615-3330-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation